Cargando…
Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence o...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170293/ https://www.ncbi.nlm.nih.gov/pubmed/32150329 http://dx.doi.org/10.1002/acm2.12844 |
_version_ | 1783523865113133056 |
---|---|
author | Hirayama, Shusuke Matsuura, Taeko Yasuda, Koichi Takao, Seishin Fujii, Takaaki Miyamoto, Naoki Umegaki, Kikuo Shimizu, Shinichi |
author_facet | Hirayama, Shusuke Matsuura, Taeko Yasuda, Koichi Takao, Seishin Fujii, Takaaki Miyamoto, Naoki Umegaki, Kikuo Shimizu, Shinichi |
author_sort | Hirayama, Shusuke |
collection | PubMed |
description | PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence of RBE on the linear energy transfer (LET). To conduct as accurate a clinical evaluation as possible in this circumstance, it is desirable that the dosimetric parameters derived by TPS ([Formula: see text]) are close to the “true” values derived with the variable RBE models ([Formula: see text]). As such, in this study, the closeness of [Formula: see text] to [Formula: see text] was compared between planning target volume (PTV)‐based and robust plans. METHODS: Intensity‐modulated proton therapy (IMPT) treatment plans for two Radiation Therapy Oncology Group (RTOG) phantom cases and four nasopharyngeal cases were created using the PTV‐based and robust optimizations, under the assumption of a constant RBE of 1.1. First, the physical dose and dose‐averaged LET (LET(d)) distributions were obtained using the analytical calculation method, based on the pencil beam algorithm. Next, [Formula: see text] was calculated using three different RBE models. The deviation of [Formula: see text] from [Formula: see text] was evaluated with D (99) and D (max), which have been used as the evaluation indices for clinical target volume (CTV) and organs at risk (OARs), respectively. The influence of the distance between the OAR and CTV on the results was also investigated. As a measure of distance, the closest distance and the overlapped volume histogram were used for the RTOG phantom and nasopharyngeal cases, respectively. RESULTS: As for the OAR, the deviations of [Formula: see text] from [Formula: see text] were always smaller in robust plans than in PTV‐based plans in all RBE models. The deviation would tend to increase as the OAR was located closer to the CTV in both optimization techniques. As for the CTV, the deviations of [Formula: see text] from [Formula: see text] were comparable between the two optimization techniques, regardless of the distance between the CTV and the OAR. CONCLUSION: Robust optimization was found to be more favorable than PTV‐based optimization in that the results presented by TPS were closer to the “true” values and that the clinical evaluation based on TPS was more reliable. |
format | Online Article Text |
id | pubmed-7170293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71702932020-04-21 Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations Hirayama, Shusuke Matsuura, Taeko Yasuda, Koichi Takao, Seishin Fujii, Takaaki Miyamoto, Naoki Umegaki, Kikuo Shimizu, Shinichi J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: While a large amount of experimental data suggest that the proton relative biological effectiveness (RBE) varies with both physical and biological parameters, current commercial treatment planning systems (TPS) use the constant RBE instead of variable RBE models, neglecting the dependence of RBE on the linear energy transfer (LET). To conduct as accurate a clinical evaluation as possible in this circumstance, it is desirable that the dosimetric parameters derived by TPS ([Formula: see text]) are close to the “true” values derived with the variable RBE models ([Formula: see text]). As such, in this study, the closeness of [Formula: see text] to [Formula: see text] was compared between planning target volume (PTV)‐based and robust plans. METHODS: Intensity‐modulated proton therapy (IMPT) treatment plans for two Radiation Therapy Oncology Group (RTOG) phantom cases and four nasopharyngeal cases were created using the PTV‐based and robust optimizations, under the assumption of a constant RBE of 1.1. First, the physical dose and dose‐averaged LET (LET(d)) distributions were obtained using the analytical calculation method, based on the pencil beam algorithm. Next, [Formula: see text] was calculated using three different RBE models. The deviation of [Formula: see text] from [Formula: see text] was evaluated with D (99) and D (max), which have been used as the evaluation indices for clinical target volume (CTV) and organs at risk (OARs), respectively. The influence of the distance between the OAR and CTV on the results was also investigated. As a measure of distance, the closest distance and the overlapped volume histogram were used for the RTOG phantom and nasopharyngeal cases, respectively. RESULTS: As for the OAR, the deviations of [Formula: see text] from [Formula: see text] were always smaller in robust plans than in PTV‐based plans in all RBE models. The deviation would tend to increase as the OAR was located closer to the CTV in both optimization techniques. As for the CTV, the deviations of [Formula: see text] from [Formula: see text] were comparable between the two optimization techniques, regardless of the distance between the CTV and the OAR. CONCLUSION: Robust optimization was found to be more favorable than PTV‐based optimization in that the results presented by TPS were closer to the “true” values and that the clinical evaluation based on TPS was more reliable. John Wiley and Sons Inc. 2020-03-09 /pmc/articles/PMC7170293/ /pubmed/32150329 http://dx.doi.org/10.1002/acm2.12844 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Hirayama, Shusuke Matsuura, Taeko Yasuda, Koichi Takao, Seishin Fujii, Takaaki Miyamoto, Naoki Umegaki, Kikuo Shimizu, Shinichi Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title | Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title_full | Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title_fullStr | Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title_full_unstemmed | Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title_short | Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations |
title_sort | difference in let‐based biological doses between impt optimization techniques: robust and ptv‐based optimizations |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170293/ https://www.ncbi.nlm.nih.gov/pubmed/32150329 http://dx.doi.org/10.1002/acm2.12844 |
work_keys_str_mv | AT hirayamashusuke differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT matsuurataeko differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT yasudakoichi differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT takaoseishin differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT fujiitakaaki differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT miyamotonaoki differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT umegakikikuo differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations AT shimizushinichi differenceinletbasedbiologicaldosesbetweenimptoptimizationtechniquesrobustandptvbasedoptimizations |